Literature DB >> 18725113

Clinical experience using hypofractionated radiation schedules in breast cancer.

Timothy J Whelan1, Do-Hoon Kim, Jonathan Sussman.   

Abstract

Hypofractionation is attractive for whole- or partial-breast irradiation because it permits treatment to be given with fewer fractions in a shorter period of time and at less cost. A number of cohort studies suggest that hypofractionation may be given to the whole breast safely and with good local control. Recent randomized trials have confirmed that hypofractioned whole-breast irradiation is equivalent to more conventional whole-breast irradiation with respect to local recurrence and cosmetic outcome. Recently, there has been a renewed interest in hypofractionation for the delivery of partial-breast irradiation using a number of techniques including high-dose rate brachytherapy, 3-dimensional conformal radiation using external-beam techniques, and intraoperative therapy. Early cohort studies report good local control and acceptable morbidity. Randomized trials are now underway to compare this approach to conventional whole-breast irradiation.

Entities:  

Mesh:

Year:  2008        PMID: 18725113     DOI: 10.1016/j.semradonc.2008.04.008

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  25 in total

1.  A novel technique to enable experimental validation of deformable dose accumulation.

Authors:  Carolyn J Niu; Warren D Foltz; Michael Velec; Joanne L Moseley; Adil Al-Mayah; Kristy K Brock
Journal:  Med Phys       Date:  2012-02       Impact factor: 4.071

2.  Hypofractionated radiotherapy and adjuvant chemotherapy do not increase radiation-induced dermatitis in breast cancer patients.

Authors:  T Hijal; A A Al Hamad; T Niazi; K Sultanem; B Bahoric; T Vuong; T Muanza
Journal:  Curr Oncol       Date:  2010-10       Impact factor: 3.677

3.  Ten-year results of accelerated hypofractionated adjuvant whole-breast radiation with concomitant boost to the lumpectomy cavity after conserving surgery for early breast cancer.

Authors:  Domenico Cante; Edoardo Petrucci; Piera Sciacero; Cristina Piva; Silvia Ferrario; Silvia Bagnera; Sebastiano Patania; Guido Mondini; Massimo Pasquino; Valeria Casanova Borca; Giorgio Vellani; Maria Rosa La Porta; Pierfrancesco Franco
Journal:  Med Oncol       Date:  2017-08-03       Impact factor: 3.064

4.  GammaPod-a new device dedicated for stereotactic radiotherapy of breast cancer.

Authors:  Cedric X Yu; Xinyu Shao; Jin Zhang; William Regine; Mike Zheng; Ying S Yu; Jianchun Deng; Zhengcheng Duan
Journal:  Med Phys       Date:  2013-05       Impact factor: 4.071

Review 5.  Intraoperative Electron Radiotherapy (IOERT) in the Treatment of Primary Breast Cancer.

Authors:  Julia Kaiser; Roland Reitsamer; Peter Kopp; Christoph Gaisberger; Michael Kopp; Thorsten Fischer; Franz Zehentmayr; Felix Sedlmayer; Gerd Fastner
Journal:  Breast Care (Basel)       Date:  2018-05-30       Impact factor: 2.860

6.  Adjuvant chemotherapy and acute toxicity in hypofractionated radiotherapy for early breast cancer.

Authors:  Vassilis Kouloulias; Anna Zygogianni; Efrosini Kypraiou; John Georgakopoulos; Zoi Thrapsanioti; Ivelina Beli; Eftychia Mosa; Amanta Psyrri; Christos Antypas; Christina Armbilia; Maria Tolia; Kalliopi Platoni; Christos Papadimitriou; Nikolaos Arkadopoulos; Costas Gennatas; George Zografos; George Kyrgias; Maria Dilvoi; George Patatoucas; Nikolaos Kelekis; John Kouvaris
Journal:  World J Clin Cases       Date:  2014-11-16       Impact factor: 1.337

7.  Radioresistance of the breast tumor is highly correlated to its level of cancer stem cell and its clinical implication for breast irradiation.

Authors:  Xiangrong Sharon Qi; Frank Pajonk; Susan McCloskey; Daniel A Low; Patrick Kupelian; Michael Steinberg; Ke Sheng
Journal:  Radiother Oncol       Date:  2017-09-17       Impact factor: 6.280

8.  Exclusive and adjuvant radiotherapy in breast cancer patients with synchronous metastases.

Authors:  Romuald Le Scodan; David Ali; Denise Stevens
Journal:  BMC Cancer       Date:  2010-11-17       Impact factor: 4.430

9.  Hypofractionated radiotherapy has the potential for second cancer reduction.

Authors:  Uwe Schneider; Jürgen Besserer; Andreas Mack
Journal:  Theor Biol Med Model       Date:  2010-02-11       Impact factor: 2.432

Review 10.  The future of Radiation Oncology: Considerations of Young Medical Doctor.

Authors:  Bartosz Urbański
Journal:  Rep Pract Oncol Radiother       Date:  2012-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.